Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering

Biomaterials

Volumn 21, Issue 24, 2000, Pages 2521-2527

  Murphy, William L ^a   Peters, Martin C ^a   Kohn, David H ^a   Mooney, David J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bone; Drug delivery; Mineralization; Poly(lactide co glycolide); Tissue engineering; VEGF

Indexed keywords

BIODEGRADATION; BIOFILMS; BODY FLUIDS; BONE; COPOLYMERS; DRUG PRODUCTS; FILM GROWTH; GROWTH KINETICS; LEACHING; POROSITY; POROUS MATERIALS;

CELL TRANSPLANTATION; MINERALIZATION; POLYGLYCOLIDE; POLYLACTIDE; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

BIOMATERIALS;

POLYGLACTIN; POLYMER; VASCULOTROPIN;

ARTICLE; BIOENGINEERING; BONE MINERALIZATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MINERALIZATION; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0034672889     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00120-4     Document Type: Article

References (41)

1. Langer R., Vacanti J.P. Tissue Engng Sci. 260:1993;920-926.
2. Crane G.M., Ishaug S.L., Mikos A.G. Bone Tissue Engng Nat Med. 1:1995;1322-1324.
3. Putnam A.J., Mooney D.J. Tissue engineering using synthetic extracellular matrices. Nat Med. 2:1996;824-826.
4. Minabe M. A critical review of the biologic rationale for guided tissue regeneration. J Periodontol. 62:1991;171-179.
5. Kim B.S., Mooney D.J. Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res. 41:1998;322-332.
6. Gilding D.G. Biodegradable Polymers. Williams D.F. Biocompatibility of Clinical Implant materials. 1981;209-232 CRC Press, Boca Raton, FL.
7. Li S.M., Garreau H., Vert M. Structure property relationships in the case of the degradation of massive poly(. α -hydroxy acids) in aqueous media J Mater Sci Mater Med. 1:1990;123-139.
8. Harris L.D., Kim B.S., Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res. 42:1998;396-402.
9. Lo H., Ponticiello M.S., Leong K.W. Fabrication of controlled release biodegradable polymer foams by phase separation. Tissue Engng. 1:1995;15-28.
10. Mikos A.G., Thorsen A.J. Preparation and characterization of poly(L-lactic acid) foams. Polymer. 35:1994;1068-1077.
11. Murphy W.L., Kohn D.H., Mooney D.J. Growth of continuous bone-like mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res. 50:2000;50-58.
12. Hench L.L. Bioceramics. from concept to clinic J Am Ceram Soc. 74:1991;1487-1510.
13. Kokubo T. Recent progress in glass-based materials for biomedical applications. J Ceram Soc Japan. 99:1991;965-973.
14. Ripamonti U. Calvarial reconstruction in baboons with porous hydroxyapatite. J Craniofac Surg. 3:1992;149-159.
15. Ishaug-Riley S.L., Crane G.M., Gurlek A., Miller M.J., Yaszemski M.J., Yasko A.W., Mikos A.G. Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res. 36:1997;1-8.
16. Shea LD, Wang D, Francheschi RT, Mooney DJ. Bone formation from pre-osteoblasts on 3-d scaffolds. Tissue Engng, in press.
17. Giannobile W.V. Periodontal tissue engineering by growth factors. Bone. 19:1996;23S-37S.
18. Langer R. New methods of drug delivery. Science. 249:1990;1527-1532.
19. Whang K., Tsai D.C., Nam E.K., Aitken M., Sprague S.M., Patel P.K., Healy K.E. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res. 42:1998;491-499.
20. Wheeler D.L., Chamberland D.L., Schmitt J.M., Buck D.C., Brekke J.H., Hollinger J.O., Joh S., Suh K. Radiomorphometry and biomechanical assessment of recombinant human bone morphogenetic protein 2 and polymer in rabbit radius ostectomy model. J Biomed Mater Res. 43:1998;365-373.
21. Shea L.D., Smiley E., Bonadio J., Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat Biotech. 17:1999;551-554.
22. Sheridan M., Shea L.D., Peters M.C., Mooney D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Rel. 64:2000;91-102.
23. Mooney D.J., Sano K.et al. Long term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res. 37:1997;413-420.
24. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 4:1995;415-436.
25. Mikos A.G., Sarakinos G., Ingber D.E., Vacanti J., Langer R. Prevascularization of porous biodegradable polymers. Biotech Bioengng. 42:1993;716-723.
26. Mooney D.J., Kaufmann P.M., Sano K., McNamara K.M., Vacanti J.P., Langer R. Transplantation of hepatocytes using porous, biodegradable sponges. Transplant Proc. 26:1994;3425-3426.
27. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
28. Weast R.C., Astle M.J. CRC Handbook of Chemistry and Physics. 63rd ed:1983;B228 CRC Press, Boca Raton, FL.
29. Tanahashi M., Yao T., Kokubo T., Minoda M., Miyamoto T., Nakamura T., Yamamuro T. Apatite coated on organic polymers by biomimetic process. improvement in adhesion to substrate by glow discharge treatment J Biomed Mater Res. 29:1995;339-347.
30. Zhang R., Ma P.X. Porous poly(L-lactic acid)/apatite composites created by biomimetic process. J Biomed Mater Res. 45:1999;285-293.
31. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 8:1991;713-720.
32. Kwong A.K., Chou S., Sun A.M., Sefton M.V., Goosen M.F.A. In Vitro and in vivo release of insulin from poly(lactic acid) microbeads and pellets. J Control Rel. 4:1986;47-62.
33. Pekarek K.J., Jacob J.S., Mathiowitz E. Double-walled polymer microspheres for controlled drug release. Nature. 367:1994;258-260.
34. Kreitz M.R., Webber W.L., Galletti P.M., Mathiowitz E. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D, L-lactide-co-glycolide) Biomaterials. 18:1997;597-603.
35. Athanasiou K.A., Singhal A.R., Agrawal C.M., Boyan B.D. In vitro degradation and release characteristics of biodegradable implants containing trypsin inhibitor. Clin Orthop Rel Res. 315:1995;272-281.
36. Okada H., Doken Y., Ogawa Y., Toguchi H. Preparation of three month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 11:1994;1143-1147.
37. Sah H., Toddywala R., Chien Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J Control Rel. 30:1994;201-211.
38. Ishaug-Riley S.L., Crane-Kruger G.M., Yaszemski M.J., Mikos A.G. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials. 19:1998;1405-1412.
39. Hench L.L. Bioceramics. from concept to clinic J Am Ceram Soc. 74:1991;1487-1510.
40. Kokubo T. Recent progress in glass based materials for biomedical applications. J Ceram Soc Japan. 99:1991;965-973.
41. LeGeros R.Z., Daculzi G. In vivo transformation of biphasic calcium phosphate ceramics. Ultrastructural and physicochemical characterizations Handbook of Bioactive Ceramics. 1990;17-28 CRC Press, Boca Raton, FL.